ICRA upgrades long-term rating to ICRA A+ for bank facilities of Windlas Biotech; Stock gains

The credit rating agency also reaffirms the short-term rating of the company at ICRA A1.

from India Infoline News Service https://ift.tt/3u7hNcc

Comments